▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2966 by analyst upside · 2026-08-12
ICLR
ICON Public Limited Company
Healthcare · Market Cap $13B · P/E 254.7x
ANALYST PRICE TARGET
+12.1%
implied upside to consensus target
Current Price $165.58
Consensus Target $185.56
Bull Target $220.0
Bear Target $155.0
Analysts Covering 16
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
8
Hold
6
Sell
1
52-Week Low $66.57
52-Week High $203.91
YTD Return -12.2%
FUNDAMENTALS
Market Cap $13B
P/E Ratio (TTM) 254.7x
Forward P/E 13.9x
EPS (TTM) $0.65
PEG Ratio 0.54
Dividend Yield N/A
Revenue (TTM) $8.3B
Profit Margin 0.3%
52-WEEK RANGE
52-Week Low $66.57
52-Week High $203.91
Current Price $165.58
Bear Target $155.0
Bull Target $220.0
● Now $165.58 ● Target $185.56
TRADING DATA
Avg Volume 990K
YTD Return -12.2%
Analyst Count 16
Consensus Buy
Upside to Target +12.1%
Last Updated 2026-08-12

ANALYST SUMMARY

ICON Public Limited Company (ICLR) is currently trading at $165.58 with a Wall Street consensus price target of $185.56, implying potential upside of 12.1% over the next 12 months. 16 analysts currently cover ICLR, with a consensus rating of Buy - 56% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $220.0, while the most cautious has a target of $155.0.

ICLR operates in the Healthcare sector with a market capitalisation of $13B. The stock is down 12.2% year-to-date and is currently trading near the upper end of its 52-week range of $66.57 – $203.91.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

CORT +20.9%
Corcept Therapeutics Incorporated
$12B · P/E 248.6x · Buy
RGEN +12.7%
Repligen Corporation
$9B · P/E 225.7x · Buy
BMRN +29.9%
BioMarin Pharmaceutical Inc.
$13B · P/E 188.0x · Buy
ICUI +6.2%
ICU Medical, Inc.
$5B · P/E 154.3x · Buy
ALKS +13.8%
Alkermes plc
$8B · P/E 129.5x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for ICLR, with each firm's 90-day track record across all stocks we track. See full firm rankings →

TD Cowen - Reiterated
Buy → Buy 2026-06-01 Building track record
B of A Securities - Reiterated
Underperform → Underperform 2026-06-01 Building track record
Citigroup - Reiterated
Neutral → Neutral 2026-05-29 Building track record
Truist Securities - Reiterated
Hold → Hold 2026-05-29 Building track record
RBC Capital - Reiterated
Sector Perform → Sector Perform 2026-05-29 Building track record
JP Morgan - Reiterated
Neutral → Neutral 2026-05-29 43% win rate (7 calls)
Barclays - Reiterated
Equal-Weight → Equal-Weight 2026-05-29 Building track record
BMO Capital - Reiterated
Outperform → Outperform 2026-05-29 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
51
out of 100
Coverage depth
22/30
Consensus clarity
22/30
Vote unanimity
5/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →